Double-blind, randomized, placebo-controlled phase III trial of oxymetholone for the treatment of HIV wasting

No abstract is available for this paper.

• Publication year

  2003

• Venue

  AIDS (London)

• Publication date

  2003-03-28

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00002030-200303280-00008PMID 12646793
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The insulin-like growth factor system in human immunodeficiency virus infection: relations to immunological parameters, disease progression, and antiretroviral therapy.

  2001cited by this paper
• Altered Fat Distribution in HIV‐Positive Men on Nucleoside Analog Reverse Transcriptase Inhibitor Therapy

  2001cited by this paper
• Review of oxymetholone: A 17α-alkylated anabolic-androgenic steroid

  2001cited by this paper
• The effects of recombinant human growth hormone on body composition and glucose metabolism in HIV-infected patients with fat accumulation.

  2001cited by this paper
• Review of oxymetholone: a 17alpha-alkylated anabolic-androgenic steroid.

  2001cited by this paper
• Resistance exercise and oxandrolone for men with HIV-related weight loss.

  2000cited by this paper
• Effects of testosterone and progressive resistance training in eugonadal men with AIDS wasting. A randomized, controlled trial.

  2000cited by this paper
• Comparison of total body potassium with other techniques for measuring lean body mass in men and women with AIDS wasting.

  2000cited by this paper
• Treatment guidelines for HIV-associated wasting.

  2000cited by this paper
• Relation of Lean Body Mass to Health‐Related Quality of Life in Persons With HIV

  2000cited by this paper
• Thalidomide for the Treatment of AIDS-Associated Wasting

  2000cited by this paper
• Treatment guidelines for HIV-associated wasting.

  2000cited by this paper
• Nutritional treatment for acquired immunodeficiency virus-associated wasting using beta-hydroxy beta-methylbutyrate, glutamine, and arginine: a randomized, double-blind, placebo-controlled study.

  2000cited by this paper
• Resistance exercise and oxandrolone for men with HIV-related weight loss

  2000cited by this paper
• Weight loss and wasting remain common complications in individuals infected with human immunodeficiency virus in the era of highly active antiretroviral therapy.

  2000cited by this paper
• Treatments for wasting in patients with the acquired immunodeficiency syndrome.

  1999cited by this paper
• Bioelectrical impedance analysis in HIV-infected patients treated with triple antiretroviral treatment.

  1999cited by this paper
• Sustained anabolic effects of long-term androgen administration in men with AIDS wasting.

  1999cited by this paper
• Monitoring changes in fat-free mass in HIV-positive men with hypotestosteronemia and AIDS wasting syndrome treated with gonadal hormone replacement therapy.

  1999cited by this paper
• Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: a randomized controlled trial.

  1999cited by this paper
• Glutamine-antioxidant supplementation increases body cell mass in AIDS patients with weight loss: a randomized, double-blind controlled trial.

  1999cited by this paper
• Effects of nandrolone decanoate therapy in borderline hypogonadal men with HIV-associated weight loss.

  1999cited by this paper
• Effects of Androgen Administration in Men with the AIDS Wasting Syndrome

  1998cited by this paper
• De novo lipogenesis predicts short-term body-composition response by bioelectrical impedance analysis to oral nutritional supplements in HIV-associated wasting.

  1998cited by this paper
• The effect of protease inhibitors on weight and body composition in HIV‐infected patients

  1998cited by this paper
• Transdermal testosterone administration in women with acquired immunodeficiency syndrome wasting: a pilot study.

  1998cited by this paper
• Correlation between body composition, caloric intake and plasma viral load in HIV infected patients

  1997cited by this paper
• Body composition and endocrine function in women with acquired immunodeficiency syndrome wasting.

  1997cited by this paper
• Variation in body weight and plasma viral load in HIV patients treated with tritherapy including a protease inhibitor

  1997influential reference
• Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting.

  1996cited by this paper
• Oxandrolone in AIDS‐wasting myopathy

  1996cited by this paper
• Recombinant human growth hormone in patients with HIV-associated wasting. A randomized, placebo-controlled trial. Serostim Study Group.

  1996cited by this paper
• Prediction of body cell mass, fat-free mass, and total body water with bioelectrical impedance analysis: effects of race, sex, and disease.

  1996cited by this paper
• Recombinant Human Growth Hormone in Patients with HIV-Associated Wasting

  1996cited by this paper
• Oxymetholone promotes weight gain in patients with advanced human immunodeficiency virus (HIV-1) infection

  1996cited by this paper
• Safety and efficacy of nandrolone decanoate for treatment of wasting in patients with HIV infection

  1996cited by this paper
• Megestrol for AIDS-Related Anorexia

  1995cited by this paper
• Megestrol Acetate in Patients with AIDS and Cachexia

  1994cited by this paper
• Megestrol Acetate in Patients with AIDS-related Cachexia

  1994cited by this paper
• Endocrine function in the HIV wasting syndrome.

  1994cited by this paper
• Megestrol acetate in patients with AIDS-related cachexia.

  1994cited by this paper
• Prospective analysis of patterns of weight change in stage IV human immunodeficiency virus infection.

  1993cited by this paper
• Early changes of body composition in human immunodeficiency virus-infected patients: tetrapolar body impedance analysis indicates significant malnutrition.

  1993cited by this paper
• Effect of megestrol acetate on the human pituitary-adrenal axis.

  1992cited by this paper
• Sequence of changes in body composition induced by testosterone and reversal of changes after drug is stopped.

  1992influential reference
• A Health Status Questionnaire Using 30 Items From The Medical Outcomes Study: Preliminary Validation in Persons With Early HIV Infection

  1991cited by this paper
• Magnitude of body-cell-mass depletion and the timing of death from wasting in AIDS.

  1989cited by this paper
• Oxymetholone Therapy in Patients with Familial Antithrombin III Deficiency

  1988cited by this paper
• Endocrine disorders in men infected with human immunodeficiency virus.

  1988influential reference
• Severe hyperglucagonaemia during treatment with oxymetholone.

  1986cited by this paper
• The effect of anabolic steroids on lean body mass: the dose response curve.

  1985influential reference
• Reference values for body fat content as a measure for desirable body fat content.

  1984cited by this paper
• Drug induced liver disease.

  1983cited by this paper
• Anabolic Steroids.

  1983cited by this paper
• Hepatic lesions in patients on anabolic androgenic therapy.

  1983cited by this paper
• Drug-Induced Liver Disease

  1978cited by this paper
• Evaluation of the protein anabolic properties of certain orally active anabolic agents based on nitrogen balance studies in rats.

  1963cited by this paper

• An Overview of the Deadly Effects of Anabolic-Androgenic Steroids: Clinical Cases and Scientific Insights

  2025cites this paper
• Hepatotoxicity due to dietary supplements: state-of-the-art, gaps and perspectives

  2023cites this paper
• Anabolic–androgenic steroids: How do they work and what are the risks?

  2022cites this paper
• Downregulation of Androgen Receptors upon Anabolic-Androgenic Steroids: A Cause or a Flawed Hypothesis of the Muscle-Building Plateau?

  2022cites this paper
• Treatment of telomeropathies.

  2021cites this paper
• Tart Cherry (Fruit of Prunus cerasus) Concentrated Powder (TCcp) Ameliorates Glucocorticoid-Induced Muscular Atrophy in Mice

  2021influential citation
• The Prevalence of Hypogonadism and the Effectiveness of Androgen Administration on Body Composition in HIV-Infected Men: A Meta-Analysis

  2021cites this paper
• Comparable Effects of the Androgen Derivatives Danazol, Oxymetholone and Nandrolone on Telomerase Activity in Human Primary Hematopoietic Cells from Patients with Dyskeratosis Congenita

  2020cites this paper
• Effects of Testosterone Supplementation on Body Composition in HIV Patients: A Meta-analysis of Double-blinded Randomized Controlled Trials

  2018cites this paper
• Extracellular polysaccharides purified from Aureobasidium pullulans SM-2001 (Polycan) inhibit dexamethasone-induced muscle atrophy in mice

  2017cites this paper
• Androgen Therapy for Hypogonadism in Men with Chronic Illnesses

  2017cites this paper
• Highly Active Antiretroviral Therapy-Associated Metabolic Syndrome and Lipodystrophy: Pathophysiology and Current Therapeutic Interventions

  2017cites this paper
• Effect of Special Operations Training on Testosterone, Lean Body Mass, and Strength and the Potential for Therapeutic Testosterone Replacement: A Review of the Literature.

  2016influential citation
• Clinical utility of dronabinol in the treatment of weight loss associated with HIV and AIDS

  2016cites this paper
• Clinical utility of dronabinol in the treatment of weight loss associated with HIV and AIDS

  2016cites this paper
• The administration of Fructus Schisandrae attenuates dexamethasone-induced muscle atrophy in mice

  2015cites this paper
• Royal Jelly alleviates sperm toxicity and improves in vitro fertilization outcome in Stanozolol-treated mice

  2015cites this paper
• Involuntary Weight Loss

  2015cites this paper
• Protective Role of Royal Jelly in Oxymetholone-induced Oxidative Injury in Mouse Testis

  2014cites this paper
• Hypogonadism in Human Immunodeficiency Virus-Positive Men

  2014cites this paper
• Pharmacologic Management of Human Immunodeficiency Virus Wasting Syndrome

  2014cites this paper
• Effect of oral anabolic steroid on muscle strength and muscle growth in hemodialysis patients.

  2013cites this paper
• HIV and Testosterone in Men

  2013cites this paper
• Lipid metabolism of orchiectomised rats was affected by fructose ingestion and the amount of ingested fructose.

  2012cites this paper
• Mammalian Cell-Derived Somatropin

  2012cites this paper
• Short-term individual nutritional care as part of routine clinical setting improves outcome and quality of life in malnourished medical patients.

  2011cites this paper
• Position of the American Dietetic Association: Nutrition Intervention and Human Immunodeficiency Virus Infection.

  2010cites this paper
• [Theory for prophylactic AIDS vaccine development].

  2009cites this paper
• Therapeutic and protective effect of oxymetholone against mortality induced by gamma irradiation in mice

  2009cites this paper
• Performance-enhancing sports supplements: Role in critical care

  2009cites this paper
• An evidence‐based analysis of anabolic steroids as therapeutic agents in horses

  2008cites this paper
• Nutritional deficit as a negative prognostic factor in patients with miliary tuberculosis

  2008cites this paper
• Sex hormones and related compounds, including hormonal contraceptives

  2007cites this paper
• Testosterone supplementation of megestrol therapy does not enhance lean tissue accrual in men with human immunodeficiency virus-associated weight loss: a randomized, double-blind, placebo-controlled, multicenter trial.

  2007cites this paper
• ESPEN Guidelines on Enteral Nutrition: Wasting in HIV and other chronic infectious diseases.

  2006cites this paper
• Chemosensory declines in older adults with HIV: identifying interventions.

  2006cites this paper
• Mammalian cell-derived somatropin : a review of its use in the management of HIV-associated wasting.

  2006cites this paper
• Associations among body composition, androgen levels, and human immunodeficiency virus status in adolescents.

  2006cites this paper
• Oral oxymetholone reduces mortality induced by gamma irradiation in mice through stimulation of hematopoietic cells

  2006cites this paper
• Influence of Natural Honey on Biochemical and Hematological Variables in AIDS: A case study

  2006cites this paper
• Orchiectomized Fischer 344 male rat models body composition in hypogonadal state.

  2006cites this paper
• Oxandrolone in the Treatment of HIV-Associated Weight Loss in Men: A Randomized, Double-Blind, Placebo-Controlled Study

  2006cites this paper
• Intracerebroventricular self-administration of commonly abused anabolic-androgenic steroids in male hamsters (Mesocricetus auratus): nandrolone, drostanolone, oxymetholone, and stanozolol.

  2005cites this paper
• Conceptos actuales y nuevas terapéuticas para el síndrome de desgaste asociado con el virus de la inmunodeficiencia humana

  2005cites this paper
• Androgens, Anabolic Steroids, and Glucocorticoids

  2005cites this paper
• Manual of Psychiatric Care for the Medically Ill

  2005cites this paper
• Anabolic steroids for the treatment of weight loss in HIV-infected individuals.

  2005cites this paper
• Effect of nandrolone decanoate therapy on weight and lean body mass in HIV-infected women with weight loss: a randomized, double-blind, placebo-controlled, multicenter trial.

  2005cites this paper
• Treatment with nandrolone decanoate and megestrol acetate in HIV-infected men.

  2005cites this paper
• Collaborative Recommendations: The Approach to Diagnosis and Treatment of HIV Wasting

  2004cites this paper
• Efficacy of Selected Treatments of HIV Wasting: A Systematic Review and Meta-Analysis

  2004cites this paper
• Body Mass Index, Body Cell Mass, and 4‐Year All‐Cause Mortality Risk in Older Nursing Home Residents

  2004cites this paper
• Testosterone replacement for hypogonadism: clinical findings and best practices.

  2003cites this paper
• HIV and testosterone therapy.

  2003cites this paper
• Heated amphotericin to treat leishmaniasis.

  2003cites this paper
• Position of the American Dietetic Association and Dietitians of Canada: nutrition intervention in the care of persons with human immunodeficiency virus infection.

  2000cites this paper